Concentrated injection and infusion solution for intravenous administration

US6638913B1 · kind B1 · utility

Assignee

• SCHERING CORPORATION · US

Inventors

• Ulrich Speck · Berlin, DE
• Gabriele Schuhmann-Giampieri · Berlin, DE
• Peter Muschick · Ladenburg, DE
• Werner Krause · Plantsville, US

Key dates

• Filing date: Feb 14, 2000
• Grant date: Oct 28, 2003
• Expiry date: Feb 14, 2020

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K47/20
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Additives to concentrated injection and infusion solutions that avoid or mitigate acute or delayed hypersensitivity reactions as well as injection and infusion solutions that contain these additives are described.